Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)			1 Months Ended				2 Months Ended	3 Months Ended		12 Months Ended
		Dec. 13, 2014	Mar. 31, 2016	Nov. 18, 2014	Oct. 31, 2014	Jul. 31, 2014	Feb. 29, 2016	Mar. 31, 2015	Dec. 31, 2014	Mar. 31, 2016	Mar. 31, 2015	Oct. 31, 2015
Summary Of Significant Accounting Policies [Line Items]
Expected term		6 years	5 years	6 years	6 years	6 years		6 years	6 years	5 years 5 months 12 days
Risk free interest rate		1.62%	1.20%	1.47%	1.62%	1.63%		1.48%	1.62%	1.37%
Expected volatility rate		62.90%	65.80%	62.10%	62.90%	63.70%	133.00%	62.10%	62.90%	62.00%
Share Price		$ 3.90	$ 6.00	$ 4.60	$ 4.30	$ 5.90	$ 5.79	$ 3.40	$ 3.90	$ 6.00	$ 3.40
Debt Instrument, Convertible, Conversion Price			$ 8							$ 8
Financial Liabilities Fair Value Disclosure			$ 2,811,111					$ 2,586,854		$ 2,811,111	$ 2,586,854
Depreciation and Amortization Expense										165,620	207,063
Deferred Finance Costs, Current, Net			514,000							514,000
Proceeds from Noncontrolling Interests										$ 0	725,278
Concentration Risk, Percentage										10.00%
Payments to Noncontrolling Interests										$ 702,642	$ 600,000
Adjustments to Additional Paid in Capital, purchase of noncontrolling interest										338,000
Cash, Uninsured Amount	[1]		$ 8,800,000							8,800,000
Write off of Deferred Debt Issuance Cost										$ 175,000
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term		6 years	5 years	6 years	6 years	6 years		6 years	6 years	5 years 5 months 12 days
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate		1.62%	1.20%	1.47%	1.62%	1.63%		1.48%	1.62%	1.37%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate		62.90%	65.80%	62.10%	62.90%	63.70%	133.00%	62.10%	62.90%	62.00%
Share based Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Probability Of Future Financing With Provision Of Convertible Feature Percentage										50.00%
Noncontrolling Interest, Period Increase (Decrease), Total										$ 32,000
Reclassification Of Noncontrolling Interest to Notes Receivable										414,716
Professional Stop Loss [Member]
Summary Of Significant Accounting Policies [Line Items]
Health Care Organization, Patient Service Revenue										20,000
Medi-Cal Patients Stop Loss [Member]
Summary Of Significant Accounting Policies [Line Items]
Health Care Organization, Patient Service Revenue										$ 200,000
Warrant Liability [Member]
Summary Of Significant Accounting Policies [Line Items]
Financial Liabilities Fair Value Disclosure												$ 2,900,000
Warrant Liability One
Summary Of Significant Accounting Policies [Line Items]
Expected term										4 years 6 months	6 years
Risk free interest rate										1.13%	1.53%
Expected volatility rate										65.70%	57.40%
Share Price			$ 5.93					$ 5.00		$ 5.93	$ 5.00
Percentage For Down round financing										0.00%	100.00%
Financial Liabilities Fair Value Disclosure			$ 2,800,000					$ 2,100,000		$ 2,800,000	$ 2,100,000
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term										4 years 6 months	6 years
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate										1.13%	1.53%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate										65.70%	57.40%
Conversion Feature Liability [Member]
Summary Of Significant Accounting Policies [Line Items]
Expected term										3 years 5 months 12 days	4 years
Risk free interest rate										0.95%	1.10%
Expected volatility rate										50.70%	47.60%
Share Price			$ 6.00					$ 5.00		$ 6.00	$ 5.00
Percentage For Down round financing											100.00%
Debt Instrument, Interest Rate, Stated Percentage								8.00%			8.00%
Debt Instrument, Convertible, Conversion Price								$ 10.00			$ 10.00
Financial Liabilities Fair Value Disclosure								$ 442,358			$ 442,358
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term										3 years 5 months 12 days	4 years
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate										0.95%	1.10%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate										50.70%	47.60%
Share based Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Probability Of Future Financing With Provision Of Convertible Feature Percentage										50.00%
Warrant Liability Two
Summary Of Significant Accounting Policies [Line Items]
Expected term										5 years
Risk free interest rate										1.30%
Expected volatility rate										63.30%
Share Price			$ 6.00							$ 6.00
Percentage For Down round financing										0.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term										5 years
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate										1.30%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate										63.30%
Maximum
Summary Of Significant Accounting Policies [Line Items]
Management agreement, initial term										20 years
Minimum
Summary Of Significant Accounting Policies [Line Items]
Management agreement, initial term										10 years
Computer and Software
Summary Of Significant Accounting Policies [Line Items]
Property, Plant and Equipment, Useful Life										3 years
Furniture and fixtures
Summary Of Significant Accounting Policies [Line Items]
Property, Plant and Equipment, Useful Life										8 years
Machinery and Equipment
Summary Of Significant Accounting Policies [Line Items]
Property, Plant and Equipment, Useful Life										5 years
ApolloMed Palliative Services, LLC
Summary Of Significant Accounting Policies [Line Items]
Payments to Noncontrolling Interests										$ 148,000
ApolloMed Palliative Services, LLC | Maximum
Summary Of Significant Accounting Policies [Line Items]
Noncontrolling Interest, Ownership Percentage by Parent			56.00%							56.00%
ApolloMed Palliative Services, LLC | Minimum
Summary Of Significant Accounting Policies [Line Items]
Noncontrolling Interest, Ownership Percentage by Parent			51.00%							51.00%
Parent Company [Member]
Summary Of Significant Accounting Policies [Line Items]
Payments to Noncontrolling Interests										$ 252,000

[1] Represents less than 10%